Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management.

Obstetrical & gynecological survey - 1 Jun 2000

Fasouliotis S J, Schenker J G

Abstract excerpt

The identification of the BRCA genes, and their possible etiologic relationship with various forms of inherited cancer, has been recognized universally as a cornerstone in the search of cancer's genetic susceptibility. Female BRCA gene mutation carriers are found to carry an increased risk of developing breast or ovarian cancer and to a lesser degree, colon cancer, and male BRCA mutation carriers are also related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Making
Share to Ethics, Medical
Share to BRCA2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Genetic Testing

Share to Mutation

Share to Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 10841315
DOI: 10.1097/00006254-200006000-00023

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management.PMID 10841315Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.Semantic proximity Read ↗

BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Semantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications.Semantic proximity Read ↗

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.Semantic proximity Read ↗

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.Semantic proximity Read ↗

Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women.Semantic proximity Read ↗

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.Semantic proximity Read ↗

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.